Abstract
Incubation of bovine serum albumin (BSA), rat serum albumin or rat plasma with medium conditioned by endotoxin stimulated rat peritoneal macrophages produced an activity that released histamine from isolated rat serosal mast cells. The amount of histamine-releasing activity (HRA) produced increased with the length of the incubation period, with the concentration of albumin, with the number of macrophages stimulated, and with the duration of exposure of the macrophages to endotoxin. Moreover, the formation of the HRA showed a dependency on the pH of the incubation medium with an optimum at pH 4.5. Boiling the medium conditioned by stimulated macrophages before its incubation with albumin or including the acid protease inhibitor, pepstatin with the conditioned medium prevented the formation of HRA. The generation of HRA was not inhibited by pretreatment of the macrophages with the inhibitor of protein synthesis, cycloheximide. Media from macrophages not stimulated with endotoxin failed to generate HRA. Histamine release from mast cells in response to the HRA was inhibited by pretreatment of the cells with antimycin A and deoxyglucose or by reincubation in Ca-free Locke's solution containing a calcium chelating agent. When injected intradermally into anesthetized Evan's Blue treated rats, the generated HRA produced a change in vascular permeability that was prevented by the H1 antagonist, diphenhydramine. Treatment of the HRA with carboxypeptidase A reduced its ability to stimulate histamine release from mast cells. Histamine-Releasing Peptide (HRP), a neurotensin-related octapeptide, shown previously by us to be formed by the action of cathepsin D or pepsin on albumin, was identified by radioimmunoassay in acid: acetone extracts of the histamine-releasing activity. It is concluded that the formation of HRA is due to the actions of enzymes released from macrophages acting on albumin. It is suggested that such histamine-releasing activity could be formed during the later stages of the inflammatory response and that HRP is one of the peptides present.
Similar content being viewed by others
References
S. I. Wasserman,The mast cell and the inflammatory response. InThe mast cell. pp. 9–20 (Eds. J. Pepys and A. M. Edwards). Pitman Medical Press, London 1979.
J. Emes and T. J. Novak,Inflammation. InIntroduction to pathophysiology basic principle of the disease process. pp. 23–42. University Park Press, Baltimore, MD 1983.
J. I. Gallin, I. M. Goldstein and R. Synderman,Overview. InInflammation basic principles and clinical correlates. pp. 1–3 (Eds. J. I. Gallin, I. M. Goldstein and R. Snyderman). Raven Press, New York, NY 1988.
G. Weissman, J. E. Smolen and H. M. Korchal,Release of inflammatory mediators from stimulated neutrophils. New Engl. J. Med.303, 27–34 (1980).
D. Chandler, G. Meusel, E. Schumaker and G. Stapleton,FMLP-induced enzyme released from neutrophils: A role for intracellular calcium. Am. J. Physiol.245, C196-C202 (1983).
E. R. Unanue,Secretory function of mononuclear phagocytes. Am. J. Pathol.46, 450–461 (1976).
A. C. Allison, J. Ferluga, H. Prydz and H. U. Schorlemmer,The role of macrophage activation in chronic inflammation. Agents and Actions8, 27–33 (1978).
R. van Furth,Phagocytic cells: Development and distribution of mononuclear phagocytes in normal steady state and inflammation. InInflammation: Basic principles and clinical correlates. pp. 281–295 (Eds. J. I. Gallin, I. M. Goldstein and R. Snyderman). Raven Press, New York, NY 1988.
T. Reike and Z. Werb,Secretory products of marcophages and their physiological functions. Am. J. Phsyiol.246, C1–C9 (1984).
E. A. Cohn and E. Wiener,The particulate hydrolyses of macrophages. I. Comparative enzymology, isolation, and properties. J. Exp. Med.118, 991–1008 (1963a).
E. A. Cohn and E. Wiener,The particulate hydrolyses of macrophages II. Biochemical and morphological response to particle ingestion. J. Exp. Med.118, 1009–1019 (1963b).
J. Schnyder and M. Baggiolini,Secretion of lysosomal hydrolyses by stimulated and nonstimulated macrophages. J. Exp. Med.148, 435–450 (1978).
R. F. Lemanske and M. Kaliner,Mast cell dependent late phase reactions. Clin. Immunol. Rev.1, 547–580 (1982).
H. P. Godfrey, C. Ilardi, W. Engber and F. M. Graziano,Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis & Rheumatism.27, 852–856 (1984).
S. Strobel, A. Busuttil and A. Ferguson,Human intestinal mucosal mast cells: expanded population in untreated coeliac disease. Gut24, 222–227 (1983).
D. E. Cochrane, W. Boucher and R. E. Carraway,Generation of histamine-releasing activity from serum albumin in medium derived from stimulated neutrophils of rat. Brit. J. Pharmacol.97, 524–532 (1989).
R. E. Carraway, D. E. Cochrane, W. Boucher and S. Mitra,Structures of histamine releasing peptides formed by the action of acid proteases on mammalian albumin (s). J. Immunol.143, 1680–1684 (1989).
D. E. Cochrane and W. W. Douglas,Calcium-induced extrusion of secretory granules (exocytosis) in mast cells exposed to 48/80 or the ionophores A-23187 and X-537 A. Proc. Nat. Acad. Sci U.S.A.71, 408–412 (1974).
P. C. Bibb, D. E. Cochrane and N. Morel-Laurens,Loss of quinn 2 accompanies degranulation of mast cells. FEBS Letters209, 169–174 (1986).
A. Volkman and J. L. Gowans,The production of macrophages in the rat. Am. J. Pathol.46, 50–61 (1965).
A. Volkman,The origin and turnover of mononuclear cells in peritoneal exudates in rats. J. Exp. Med.124, 241–253 (1966).
D. E. Cochrane, W. W. Douglas, T. Mouri and Y. Nagazato,Calcium stimulus-secretion coupling in the adrenal medulla; contrasting stimulatory effects of the ionophores X-537A and A23187 on catecholamine outputs. J. Physiol.252, 263–278 (1975).
R. E. Carraway, S. Mitra and D. E. Cochrane,Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J. Biol. Chem.262, 5968–5973 (1987).
P. M. Henson, J. E. Henson, C. Fittschen, G. Kimani, D. L. Bratton and D. W. H. Riches, InInflammation: Basic prinicples and clinical correlates. pp. 363–390 (Eds. J. I. Gallin, I. M. Goldstein and R. Snyderman). Raven Press, New York, NY 1988.
A. R. Johnson and E. G. Erdos,Release of histamine from mast cells by vasoactive peptides. Proc. Soc. Exp. Biol. Med.142, 1252–1256 (1973).
C. M. S. Fewtrell, J. C. Foreman, C. C. Jordan, P. Oehme, H. Reuner and J. M. O'Stewart,The effect of substance P on histamine and 5′-hydroxytryptamine release in the rat. J. Physiol.330, 393–441 (1982).
R. E. Carraway, D. E. Cochrane, J. B. Lansman, S. E. Leeman, B. M. Patterson and H. J. Welch,Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J. Physiol.323, 403–414 (1982).
J. C. Foreman,The pharmacological control of immediate hypersensitivity. J. Immunol.135, 2027–2032 (1981).
K. Sugiyama, T. Ogino and K. I. Ogata,Histamine release induced by proteolytic digests of human serum albumin: Isolation and structure of an active fragment from pepsin treatment. Japan J. Pharmacol.49, 165–171 (1989).
A. R. Poole, R. M. Hembury, J. T. Dingle, I. Pinder, E. F. J. Ring and J. Cash,Secretion and localization of cathepsin D in synovial tissues removed from rheumatoid and traumatized joints. Arth. & Rheumat.19, 1287–1294 (1976).
G. P. Kerby and S. M. Taylor,Enzymatic activity in human synovial fluid from rheumatoid and non-rheumatoid patients. P.S.E.B.M.126, 865–868 (1967).
D. A. Lowther, G. C. Gillard, E. Baxter, C. J. Handlu and K. A. Rich,Carrageenan-induced arthritis. III Proteolytic enzyme present in rabbit knee joints offer a single intraatricular injection of carrageenan. Arthritis and Rheumat.19, 1287–1294 (1976).
D. O. Thueson, L. S. Speck, M. A. Lett-Brown and J. A. Grant,Histamine-releasing activity (HRA). I Production by mitogen- or antigen-stimulated human mononuclear cells. J. Immunol.123, 626–632 (1979a).
D. O. Thueson, L. S. Speck, M. A. Lett-Brown and J. A. Grant,Histamine-releasing activity (HRA). II Interaction with basophils and physiochemical characterization. J. Immunol.123, 633–639 (1979b).
A. P. Kaplan, M. Haak-Frendscho, A. Fauci, C. Dinarello and E. Halbert,A histamine-releasing factor from activated human mononuclear cells. J. Immunol.135, 2027–2032 (1985).
E. S. Schulman, M. C. Liu, D. Proud, D. W. MacGlashan Jr., L. M. Lichtenstein and M. Plaut,Human lung macrophages induce histamine release from basophils and mast cells. Am. Rev. Respir. Dis.131, 230–235 (1985).
E. S. Schulman, M. C. McGettigan, T. J. Post, R. J. Vigderman and S. S. Shapiro,Human monocytes generate basophil histamine-releasing activities. J. Immunol.140, 2369–2375 (1988).
M. C. Liu, D. Proud, L. M. Lichtenstein, D. W. MacGlashan Jr., R. S. Schleimer, N. F. Adkinson Jr., A. Kagey-Sobotka, E. S. Schulman and M. Plaut,Human lung macrophagederived histamine releasing activity is due to IgE-dependent factors. J. Immunol.136, 2588–2595 (1986).
R. F. Lemanske Jr. and M. Kaliner,Mast cell-dependent late phase reactions. Clin. Immunol. Rev.1, 547–580 (1982).
M. A. Orchard, A. Kagey-Sobotka, D. Proud and L. M. Lichtenstein,Basophil histamine released induced by a substance from stimulated human platelets. J. Immunol.136, 2240–2245 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cochrane, D.E., Boucher, W. & Carraway, R.E. Formation of histamine-releasing activity from albumin by medium conditioned by endotoxin-stimulated rat peritoneal macrophages. Agents and Actions 35, 19–28 (1992). https://doi.org/10.1007/BF01990946
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01990946